805 related articles for article (PubMed ID: 25877605)
1. [The value of maternal first and second trimester serum data of β-hCG, PAPP-A, AFP and uE3 in the prediction of preeclampsia].
Gu W; Lin J; Hou Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):101-7. PubMed ID: 25877605
[TBL] [Abstract][Full Text] [Related]
2. The role of serum markers PAPP-A β-hCG, AFP, and uE3 in predicting the risk of preeclampsia in early, middle, and late pregnancy.
Zhang W; Liang H
Technol Health Care; 2023; 31(3):1027-1037. PubMed ID: 36442168
[TBL] [Abstract][Full Text] [Related]
3. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
4. [Predictive value analysis of Down's screening serological indicators in the second trimester for gestational hypertension].
Feng C; Liu XW; Wang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Jun; 55(6):747-751. PubMed ID: 34139815
[No Abstract] [Full Text] [Related]
5. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
Hu Z; Liu X; Li L; Jia C; Li D; Liu R
Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246
[TBL] [Abstract][Full Text] [Related]
6. Multiple marker second trimester serum screening for pre-eclampsia.
Wald NJ; Morris JK
J Med Screen; 2001; 8(2):65-8. PubMed ID: 11480445
[TBL] [Abstract][Full Text] [Related]
7. The best marker combination using the integrated screening test approach for detecting various chromosomal aneuploidies.
Maymon R; Sharony R; Grinshpun-Cohen J; Itzhaky D; Herman A; Reish O
J Perinat Med; 2005; 33(5):392-8. PubMed ID: 16238533
[TBL] [Abstract][Full Text] [Related]
8. Maternal Serum PLGF, PAPPA, β-hCG and AFP Levels in Early Second Trimester as Predictors of Preeclampsia.
Duan H; Zhao G; Xu B; Hu S; Li J
Clin Lab; 2017 May; 63(5):921-925. PubMed ID: 28627818
[TBL] [Abstract][Full Text] [Related]
9. Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia.
Huang T; Bedford HM; Rashid S; Rasasakaram E; Priston M; Mak-Tam E; Gibbons C; Meschino WS; Cuckle H; Mei-Dan E
BMC Pregnancy Childbirth; 2022 Mar; 22(1):190. PubMed ID: 35260099
[TBL] [Abstract][Full Text] [Related]
10. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.
Spencer K; Yu CK; Cowans NJ; Otigbah C; Nicolaides KH
Prenat Diagn; 2005 Oct; 25(10):949-53. PubMed ID: 16086443
[TBL] [Abstract][Full Text] [Related]
11. First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study.
Keikkala E; Koskinen S; Vuorela P; Laivuori H; Romppanen J; Heinonen S; Stenman UH
BMC Pregnancy Childbirth; 2016 Nov; 16(1):378. PubMed ID: 27887594
[TBL] [Abstract][Full Text] [Related]
12. First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction.
Yu N; Cui H; Chen X; Chang Y
Taiwan J Obstet Gynecol; 2017 Jun; 56(3):358-361. PubMed ID: 28600048
[TBL] [Abstract][Full Text] [Related]
13. Cross-trimester repeated measures testing for Down's syndrome screening: an assessment.
Wright D; Bradbury I; Malone F; D'Alton M; Summers A; Huang T; Ball S; Baker A; Nix B; Aitken D; Crossley J; Cuckle H; Spencer K
Health Technol Assess; 2010 Jul; 14(33):1-80. PubMed ID: 20624355
[TBL] [Abstract][Full Text] [Related]
14. Appropriate biochemical parameters in first-trimester screening for Down syndrome.
Cuckle HS; van Lith JM
Prenat Diagn; 1999 Jun; 19(6):505-12. PubMed ID: 10416963
[TBL] [Abstract][Full Text] [Related]
15. First trimester hyperglycosylated human chorionic gonadotrophin in serum - a marker of early-onset preeclampsia.
Keikkala E; Vuorela P; Laivuori H; Romppanen J; Heinonen S; Stenman UH
Placenta; 2013 Nov; 34(11):1059-65. PubMed ID: 23993394
[TBL] [Abstract][Full Text] [Related]
16. Second-trimester Maternal Serum Screening Biomarkers in the Risk Assessment for Preeclampsia.
Long W; Zhou Q; Wang H; Lu B; Chen Y; Zhang B; Zhou W; Yu B
Ann Clin Lab Sci; 2018 May; 48(3):308-313. PubMed ID: 29970433
[TBL] [Abstract][Full Text] [Related]
17. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
[TBL] [Abstract][Full Text] [Related]
18. Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34 weeks.
Bakalis S; Gallo DM; Mendez O; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Aug; 46(2):208-15. PubMed ID: 25826797
[TBL] [Abstract][Full Text] [Related]
19. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of maternal serum multiple marker screening for early detection of gestational diabetes mellitus in the absence of a gold standard test.
Amini M; Kazemnejad A; Zayeri F; Montazeri A; Rasekhi A; Amirian A; Kariman N
BMC Pregnancy Childbirth; 2020 Jun; 20(1):375. PubMed ID: 32591020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
